D49.7
Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
Clinical Classification Guidelines
Excludes Type 1
- neoplasm of unspecified behavior of peripheral, sympathetic, and parasympathetic nerves and ganglia (D49.2)
Medical Intelligence & Overview
ICD-10 Code D49.7 refers to a neoplasm of unspecified behavior affecting endocrine glands and other parts of the nervous system. This classification indicates the presence of abnormal cellular growth, which may be benign or malignant, in these specific regions. Because the behavior of the tumor isn’t specified, further medical evaluation is needed to determine the nature and appropriate management of the condition.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting cell growth and division. Exposure to certain environmental toxins or radiation. Family history of endocrine or nervous system tumors. Pre-existing genetic syndromes associated with tumor development. Unknown factors, as the exact cause often remains unidentified.
Key Symptoms: Localized swelling or lump in affected areas. Unexplained pain or discomfort in endocrine glands or nervous tissue. Hormonal imbalances causing symptoms like irregular menstrual periods, rapid heartbeat, or unexplained weight changes. Neurological issues such as headaches, vision problems, or neurological deficits if nervous tissue is involved. General fatigue or unexplained weight loss.
Diagnostic & Treatment
Diagnosis Path: Diagnosing a neoplasm of uncertain behavior involves multiple steps, including:
Treatment Protocols: Treatment options depend on factors like tumor size, location, and whether it’s benign or malignant, and may include:
Clinical Advice & FAQs
Billing Guidance
Is D49.7 a billable ICD-10 code?
Yes, D49.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D49.7?
Clinical documentation must specify the nature of Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
